Obesity is a complex condition so many factors contribute to its occurrence (and reoccurrence) over time, and these factors are not the same for all people, says Gudzune
Nausea, diarrhea, decreased appetite, vomiting, and constipation occur in a dose-dependent manner, with higher rates at maximum doses, and typically diminish in severity as treatment continues
Important safety considerations include a boxed warning for thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2), risk of pancreatitis, gallbladder disease, and acute kidney injury with dehydration
Awareness of diabetes care has improved across the country in recent years
During the initial 2.5 mg phase, a smaller vial with a 30-day BUD gives you four to six doses with minimal leftover